Viant said the acquisition of Fremont, Calif.-based Meraqi will expand its range of interventional technologies, bioelectronics and minimally invasive surgical devices. It will also offer a West Coast design and development hub to compliment Viant’s East Coast D&D center and global network, the company said in a news release.
Foxborough, Mass.-based Viant said it plans to integrate Meraqi’s engineering and design capabilities to expand product offerings, optimize supply chains and improve quality while managing costs.
Viant partnered with Water Street Healthcare Partners and JLL Partners in 2016 to help it expand its design, development and manufacturing portfolio. In July of this year, the company announced the appointment of Alton Shader as CEO.
Viant said it believes the Meraqi acquisition will be its next step forward in the medtech space. Financial details of the acquisition were not disclosed.
“Meraqi stands out for its deep technical knowledge, passion for innovation and agility to help customers advance their technologies,” Declan Smyth, president of franchise at Viant, said in the release. “Adding Meraqi’s expertise to Viant’s breadth of capabilities and global scale provides our customers with expanded access to end-to-end solutions for all their medtech needs.”
“Joining Viant will give our customers access to a world-class, quality-focused organization with global manufacturing facilities and scale,” added Meraqi founder Al Hershey. “Additionally, this will enable Meraqi to accelerate the expansion of our capabilities and better serve our customers. Our shared passion for supporting innovative devices to address unmet patient needs and loving what we do makes this a very exciting time for our two companies and for our customers.”
In July 2018, Viant (then MedPlast, LLC) acquired Integer Holding Corporation’s Advanced Surgical and Orthopedics business. In 2017, the company acquired Coastal Life Technology and Vention Medical’s Device Manufacturing Services business.